ASCO 2022 Conference Coverage
ASCO 2022 on Olaparib + Abiraterone as 1L Therapy for mCRPC: Pharmacokinetics Data From the PROpel Trial
By
ASCO 2022 Conference Coverage
FEATURING
Andrew Armstrong
By
ASCO 2022 Conference Coverage
FEATURING
Andrew Armstrong
Login to view comments.
Click here to Login
GU